Literature DB >> 2589378

New oral and parenteral quinolones. A summary.

H C Neu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2589378     DOI： 10.1016/0002-9343(89)90081-8

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  5 in total

1.  Sequential antimicrobial therapy: a realistic approach to cost containment?

Authors:  D R Guay
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

Review 2.  Oral ciprofloxacin: a pharmacoeconomic evaluation of its use in the treatment of serious infections.

Authors:  J A Balfour; D Faulds
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

3.  Empirical antibiotic treatment of sepsis in non-neutropenic patients: single agent or combination therapy?

Authors:  M Extermann; C Regamey
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

Review 4.  Human immunodeficiency virus (HIV) infection. Does it increase susceptibility to adverse drug reactions?

Authors:  G E Harb; M A Jacobson
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

Review 5.  Do we need an intravenous fluoroquinolone?

Authors:  D S Maddix; L Warner
Journal:  West J Med       Date:  1992-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.